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INSIGHT
CELL FATE CHOICE
Ready, set, differentiate!
The expression of E-Cadherin, a protein best known for its role in cell 
adhesion, regulates the onset of embryonic differentiation.
MARGARIDA SANCHO AND TRISTAN A RODRÍGUEZ
In mammals, during the early stages of develop-ment, the embryonic cells are similar and have the ability to become all the different cell types 
of the foetus—a property known as pluripotency. 
As such, a number of questions have fascinated 
cell and developmental biologists right from 
the birth of their fields. How and when do these 
embryonic stem cells stop being pluripotent and 
start to become different from each other? And 
how do they commit to becoming a specific type 
of cell?
To date, research has focussed on the signal-
ling molecules, transcription factors and epigenetic 
processes that control this transition. Now, in eLife, 
Sally Lowell and colleagues at the University of 
Edinburgh—including Mattias Malaguti as the 
first author—supply a new twist to this story. They 
find that exposing pluripotent cells to different 
signals will pre-determine their fate: however, 
the process of differentiation can only begin once 
the expression of E-cadherin, a protein widely 
known for its role in cell adhesion, has been down-
regulated (Malaguti et al., 2013).
The BMP pathway—where BMP is short for 
bone morphogenic protein—has been widely 
studied by developmental biologists, and evi-
dence from a wide variety of model organisms, 
including frogs and mice, shows that BMPs pre-
vent pluripotent cells from becoming neural cells 
during early development (Vonica and Brivanlou, 
2006; Di-Gregorio et al., 2007). Furthermore, in 
mice, this is achieved via the up-regulation of 
genes that code for Id proteins (Ying et al., 
2003). The BMP pathway is also involved in the 
formation and development of the mesoderm—
the layer of cells in the early embryo that differ-
entiate to become muscles, connective tissues 
and some blood cells (Kishigami and Mishina, 
2005). However, we know very little about the 
mechanisms through which BMP is involved in 
all these processes.
Malaguti et al. have tackled this problem by 
analysing which cells respond to BMPs in early 
mouse embryos. They found that Id1, a gene 
up-regulated in response to BMP signalling, is 
activated in those cells that lie at the posterior 
of the embryo and that are about to form the 
mesoderm: however, this gene is not activated 
within the mesoderm itself. Furthermore, treat-
ment of embryonic stem cells with BMPs during 
the first stages of their differentiation did not 
necessarily commit these cells to the mesoderm. 
Rather, it led them to express molecular markers 
that are characteristic of epithelial, mesodermal 
and pluripotent cells, all at the same time. Therefore, 
rather than inducing mesoderm differentiation 
per se, BMP seems to instead ‘prime’ pluripotent 
cells, making them ready for this change.
The observation that BMP caused pluripotent 
cells to remain epithelial by sustaining expression 
of E-Cadherin led Malaguti et al. to hypothesize 
that this protein could be the key factor down-
stream of BMPs in pluripotency. This hypothesis 
is intriguing as it suggests that E-Cadherin is 
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involved (along with BMPs) in inhibiting the differ-
entiation of stem cells into neural cells. At a first 
look this would seem unlikely because although 
E-Cadherin has been implicated in the regula-
tion of pluripotency (Chou et al., 2008; Faunes 
et al., 2013; Livigni et al., 2013), it is best known 
as a protein involved in cell adhesion. The down-
regulation of E-Cadherin is key for ‘epithelial to 
mesenchymal transitions’ in the early embryo: 
these transitions allow future mesoderm cells 
to detach from their pluripotent neighbours 
and move to form the mesoderm (Nieto, 2013). 
Importantly, no such transition has been described 
during neural differentiation.
However, Malaguti et al. challenged this view 
by showing that, when pluripotent cells differen-
tiate into neural lineages, the expression of genes 
associated with pluripotency declined in concert 
with E-Cadherin expression. Further, the inhibition 
of E-Cadherin accelerated and increased the 
efficiency of this differentiation. This argues that 
down-regulation of E-Cadherin promotes neural 
differentiation, but does it mean that the main 
role of BMP signalling in pluripotency is to main-
tain E-Cadherin expression? This question was 
answered by Malaguti et al. with an elegant 
experiment which tested the effect of different 
levels of BMPs in cells where E-Cadherin has 
been inhibited. They found that low levels of 
BMP could not block neural differentiation when 
E-Cadherin is blocked, but high levels of BMP 
drove the cells to a primed mesoderm fate inde-
pendent of E-Cadherin. Therefore BMP signalling 
has at least two separate roles in pluripotent 
cells: to repress neural identity by maintaining 
E-Cadherin expression, and to prime them for 
mesoderm formation.
These findings raise some fundamental ques-
tions: For example, what is the role of E-Cadherin 
in pluripotent stem cells? And how does its down-
regulation lead to differentiation? To start to 
answer these questions it is important to consider 
the series of events that leads to cells becoming 
destined to become neural tissue. In the mouse 
embryo, when the future neural cells lose BMP 
signalling, they start to express molecular mark-
ers that are characteristic of the future brain 
whilst remaining pluripotent (Di-Gregorio et al., 
2007; Osorno et al., 2012) and continuing to 
express E-Cadherin (Malaguti et al., 2013). This 
suggests that a cell’s first step in committing to 
a neural fate is likely to occur after the loss of 
BMP signalling and before the down-regulation 
of E-Cadherin. As such, E-Cadherin appears to 
allow pluripotent cells to remain in a state of dual 
identity for a short time: during this time the fates 
of the cells have essentially been determined, but 
they still have the potential to choose other fates.
It is tempting to speculate that by keeping 
cells pluripotent while the first step of commit-
ment occurs, E-Cadherin ensures that, within a 
population of stem cells, all cells respond to a 
signalling molecule in a coordinated fashion. This 
would prevent the first cells that see the signal 
from ‘jumping the gun’ and initiating differentia-
tion without their neighbours. In this way the cells in 
the early embryo would first respond to the dif-
ferent levels of BMP signalling: high levels of BMP 
would prime pluripotent cells to become part of the 
mesoderm, and low BMP levels would encourage 
differentiation into neuronal cells. Subsequently, 
when the levels of E-Cadherin are down-regulated, 
all the cells would lose their pluripotency and 
start to differentiate into their pre-destined fate 
in a co-ordinated manner (Figure 1).
Figure 1. The influence of bone morphogenic protein 
(BMP) on cell fate choice. Pluripotent cells can become 
many different types of cells so they have to ‘choose’ 
their fate at some point. Malaguti et al. suggest that 
exposure to different levels of BMPs can pre-determine 
this choice: low levels of BMP (top) prime the pluripotent 
cells to become neural cells, whereas high BMP levels 
(bottom) prime the pluripotent cells to become part 
of the mesoderm. The expression of E-Cadherin (Cdh1) 
in response to BMP signalling maintains cells that are 
already committed to a particular fate in a pluripotent 
stage: however, cells only differentiate to adopt this fate 
once E-Cadherin has been down-regulated. The cells 
that are primed to become part of the mesoderm 
express a specific molecular marker (T+) and undergo 
an epithelial to mesenchymal transition (EMT) as they 
differentiate.
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Moreover, it was recently shown that embry-
onic stem cells can also form the types of cells 
that are found in the extra-embryonic tissues, 
namely the placenta and yolk-sac (Morgani et al., 
2013). This raises another question: could it be 
that E-Cadherin is determining the sensitivity of 
cells to developmental signals in the first cell fate 
choices that occur during mammalian develop-
ment, namely those that determine an embryonic 
or an extra-embryonic fate?
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